Evidence map›Paper›PMID 34556809›Full record

ArticleCell death and differentiation2022

LIN28A enhances regenerative capacity of human somatic tissue stem cells via metabolic and mitochondrial reprogramming.

Kelvin Pieknell, Yanuar Alan Sulistio, Noviana Wulansari, Wahyu Handoko Wibowo Darsono, Mi-Yoon Chang, Ji-Yun Ko, Jong Wook Chang, Min-Jeong Kim, Man Ryul Lee, Sang A Lee and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Metabolic control of induced pluripotency.Frontiers in cell and developmental biology · 2023
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 1 country.

Kelvin Pieknell *Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, South Korea.
Yanuar Alan Sulistio *Hanyang Biomedical Research Institute, Hanyang University, Seoul, South Korea. sulistio@hanyang.ac.kr.ORCID http://orcid.org/0000-0002-6701-6133
Noviana WulansariHanyang Biomedical Research Institute, Hanyang University, Seoul, South Korea.
Wahyu Handoko Wibowo DarsonoHanyang Biomedical Research Institute, Hanyang University, Seoul, South Korea.
Mi-Yoon ChangHanyang Biomedical Research Institute, Hanyang University, Seoul, South Korea.
Ji-Yun KoResearch Institute for Integrative Regenerative Biomedical Engineering, Dongguk University, Goyang-si, South Korea.
Jong Wook ChangSamsung Medical Center, Stem Cell and Regenerative Medicine Institute, Seoul, 06351, South Korea.
Min-Jeong KimSamsung Medical Center, Stem Cell and Regenerative Medicine Institute, Seoul, 06351, South Korea.
Man Ryul LeeSoonchunhyang Institute of Medibioscience (SIMS), Soonchunhyang University, Cheonan, Chungcheongnam-do, 31151, South Korea.
Sang A LeeSoonchunhyang Institute of Medibioscience (SIMS), Soonchunhyang University, Cheonan, Chungcheongnam-do, 31151, South Korea.
Hyunbeom LeeMolecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, 02792, South Korea.ORCID http://orcid.org/0000-0001-6954-7520
Gakyung LeeMolecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, 02792, South Korea.
Byung Hwa JungMolecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, 02792, South Korea.ORCID http://orcid.org/0000-0002-7504-7132
Hyunbum ParkDepartment of Chemistry, Hanyang University, Seoul, 04763, South Korea.
Geun-Ho KimDepartment of Chemistry, Hanyang University, Seoul, 04763, South Korea.
Doory KimDepartment of Chemistry, Hanyang University, Seoul, 04763, South Korea.
Gayoung ChoPaean Biotechnology, Inc, Seoul, 04552, South Korea.
Chun-Hyung KimPaean Biotechnology, Inc, Seoul, 04552, South Korea.
Dat Da LyMitohormesis Research Center, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju, Gangwon-do, 26426, South Korea.
Kyu-Sang ParkMitohormesis Research Center, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju, Gangwon-do, 26426, South Korea.ORCID http://orcid.org/0000-0003-0322-9807
Sang-Hun LeeGraduate School of Biomedical Science and Engineering, Hanyang University, Seoul, South Korea. leesh@hanyang.ac.kr.ORCID http://orcid.org/0000-0001-7553-8188
Hanyang University · KRSoonchunhyang University · KRKorea Institute of Science and Technology · KRSamsung Medical Center · KRYonsei University · KRBio-Medical Science (South Korea) · KRDongguk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing methods to improve the regenerative capacity of somatic stem cells (SSCs) is a major challenge in regenerative medicine. Here, we propose the forced expression of LIN28A as a method to modulate cellular metabolism, which in turn enhances self-renewal, differentiation capacities, and engraftment after transplantation of various human SSCs. Mechanistically, in undifferentiated/proliferating SSCs, LIN28A induced metabolic reprogramming from oxidative phosphorylation (OxPhos) to glycolysis by activating PDK1-mediated glycolysis-TCA/OxPhos uncoupling. Mitochondria were also reprogrammed into healthy/fused mitochondria with improved functional capacity. The reprogramming allows SSCs to undergo cell proliferation more extensively with low levels of oxidative and mitochondrial stress. When the PDK1-mediated uncoupling was untethered upon differentiation, LIN28A-SSCs differentiated more efficiently with an increase of OxPhos by utilizing the reprogrammed mitochondria. This study provides mechanistic and practical approaches of utilizing LIN28A and metabolic reprogramming in order to improve SSCs utility in regenerative medicine.

Indexed as

Adult Stem CellsMitochondriaCell DifferentiationCellular ReprogrammingGlycolysisHumansOxidative Phosphorylation

Identifiers

PMID34556809
PMCPMC8901931
OpenAlexW3200767313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.